Quantity size:
0.2ml
Concentration:
1mg/ml 谷氨酸脱羧酶67抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Glutamic Acid Decarboxylase (GAD) catalyzes the conversion of L glutamate to g-aminobutyric acid (GABA), the principal inhibitory neurotransmitter in the brain, and a putative paracrine signal molecule in pancreatic islets. GAD has a restricted tissue distribution. It is highly expressed in the cytoplasm of GABAergic neurons in the central nervous system (CNS) and pancreatic beta cells. It is also present in other non-neuronal tissues such as testis, oviduct and ovary. GAD is also transiently expressed in non-GABAergic cells of the embryonic and adult nervous system, suggesting its involvement in development and plasticity.
GAD exists as two isoforms, 谷氨酸脱羧酶67抗体GAD65 and GAD67 (molecular masses of 65 and 67 kD, respectively) that are encoded by two different genes. GAD65 is an ampiphilic, membraneanchored protein, (585 amino acid residues) and is encoded on human chromosome 10. GAD67 is a cytoplasmic protein (594 amino acid residues) and is encoded on chromosome 2. There is 64% amino acid identity between the two isoforms, with the highest diversity located at the N terminus, which in GAD65 is required for targeting the enzyme to GABA-containing secretory vesicles. The two isoforms appear to have distinct intraneuronal distribution in the brain. GAD65 has been identified as an autoantigen in insulindependent diabetes mellitus (IDDM) and stiff-man syndrome (SMS), IDDM is an autoimmune disease that results from T cell mediated destruction of pancreatic insulin-secreting beta cells. Islet-reactive T cells and antibodies primarily 谷氨酸脱羧酶67抗体to GAD65 (also named beta cell autoantigen) can be detected in peripheral blood of 80% of recent-onset IDD patients and in pre-diabetic high-risk subjects before onset of clinical symptoms. This suggests that GAD may be an important marker in the early stages of the disease. Also, autoantibodies to GAD65 and GAD67 are detected in animal models of IDDM, including the non-obese diabetes (NOD) mouse. In the NOD mouse, T cell reactivity is initially restricted to the C terminal regions of GAD65, but later spreads to other parts of GAD65. Stiff-man syndrome (SMS), a rare disorder of the CNS, is characterized by progressive rigidity of the body musculature with painful spasms, due to impairment of the GABAergic neurotransmission.
谷氨酸脱羧酶67抗体Also known as:
glutamate decarboxylase 67; decarboxylase 1; 67 kDa glutamic acid decarboxylase; Glutamate decarboxylase 67 kDa isoform; GAD1; GAD; GAD-67; GAD 67.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human GAD67.
●
Predicted Molecular Weight: 67kDa.
谷氨酸脱羧酶67抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl030Mu01脑型肌酸激酶(CKB)多克隆抗体Polyclonal Antibody to Creatine Kinase, Brain (CKB)
kl031Hu01白介素4受体(IL4R)多克隆抗体Polyclonal Antibody to Interleukin 4 Receptor (IL4R)
kl032Hu01白介素22(IL22)多克隆抗体Polyclonal Antibody to Interleukin 22 (IL22)
kl032Mu01白介素22(IL22)多克隆抗体Polyclonal Antibody to Interleukin 22 (IL22)
kl033Hu01热休克蛋白β8(HSPβ8)多克隆抗体Polyclonal Antibody to Heat Shock Protein Beta 8 (HSPb8)
kl033Mu01热休克蛋白β8(HSPβ8)多克隆抗体Polyclonal Antibody to Heat Shock Protein Beta 8 (HSPb8)
kl033Ra01热休克蛋白β8(HSPβ8)多克隆抗体Polyclonal Antibody to Heat Shock Protein Beta 8 (HSPb8)
kl034Hu01生长分化因子15(GDF15)多克隆抗体Polyclonal Antibody to Growth Differentiation Factor 15 (GDF15)
kl034Mu01生长分化因子15(GDF15)多克隆抗体Polyclonal Antibody to Growth Differentiation Factor 15 (GDF15)
kl034Ra01生长分化因子15(GDF15)多克隆抗体Polyclonal Antibody to Growth Differentiation Factor 15 (GDF15)
kl035Hu01S100钙结合蛋白A7(S100A7)多克隆抗体Polyclonal Antibody to S100 Calcium Binding Protein A7 (S100A7)
kl035Mu01S100钙结合蛋白A7(S100A7)多克隆抗体Polyclonal Antibody to S100 Calcium Binding Protein A7 (S100A7)
kl040Hu01葡萄糖转运蛋白2(GLUT2)多克隆抗体Polyclonal Antibody to Glucose Transporter 2 (GLUT2)
kl041Hu01过氧化物酶体增殖物激活受体δ(Pklδ)多克隆抗体Polyclonal Antibody to Peroxisome Proliferator Activated Receptor Delta (Pkld)
kl042Hu01法尼酯X受体(FXR)多克隆抗体Polyclonal Antibody to Farnesoid X Receptor (FXR)
kl042Mu01法尼酯X受体(FXR)多克隆抗体Polyclonal Antibody to Farnesoid X Receptor (FXR)
kl044Hu01肝X受体α(LXRα)多克隆抗体Polyclonal Antibody to Liver X Receptor Alpha (LXRa)
kl045Hu01存活素(Surv)多克隆抗体Polyclonal Antibody to Survivin (Surv)
kl045Mu01存活素(Surv)多克隆抗体Polyclonal Antibody to Survivin (Surv)
kl047Hu01Ki-67蛋白(Ki67P)多克隆抗体Polyclonal Antibody to Ki-67 Protein (Ki67P)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话